These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29071072)
1. Effect of high-flow nasal therapy during acute aerobic exercise in patients with chronic obstructive pulmonary disease after exacerbation: protocol for a randomised, controlled, cross-over trial. Prieur G; Medrinal C; Combret Y; Quesada AR; Prieur F; Quieffin J; Borel JC; Reychler G BMJ Open Respir Res; 2017; 4(1):e000191. PubMed ID: 29071072 [TBL] [Abstract][Full Text] [Related]
2. Nasal high flow does not improve exercise tolerance in COPD patients recovering from acute exacerbation: A randomized crossover study. Prieur G; Medrinal C; Combret Y; Dupuis Lozeron E; Bonnevie T; Gravier FE; Quieffin J; Lamia B; Borel JC; Reychler G Respirology; 2019 Nov; 24(11):1088-1094. PubMed ID: 31387158 [TBL] [Abstract][Full Text] [Related]
3. Effect of high-flow nasal therapy during exercise training in COPD patients with chronic respiratory failure: study protocol for a randomised controlled trial. Vitacca M; Pietta I; Lazzeri M; Paneroni M; Trials; 2019 Jun; 20(1):336. PubMed ID: 31176375 [TBL] [Abstract][Full Text] [Related]
4. Comparison of oxygen uptake during cycle ergometry with and without functional electrical stimulation in patients with COPD: protocol for a randomised, single-blind, placebo-controlled, cross-over trial. Medrinal C; Prieur G; Debeaumont D; Robledo Quesada A; Combret Y; Quieffin J; Contal O; Lamia B BMJ Open Respir Res; 2016; 3(1):e000130. PubMed ID: 27110364 [TBL] [Abstract][Full Text] [Related]
5. Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study. Tung LF; Shen SY; Shih HH; Chen YT; Yen CT; Ho SC Respir Res; 2020 Apr; 21(1):84. PubMed ID: 32293463 [TBL] [Abstract][Full Text] [Related]
6. High-flow nasal cannula therapy for initial oxygen administration in acute hypercapnic respiratory failure: study protocol of randomised controlled unblinded trial. Alnajada A; Blackwood B; Mobrad A; Akhtar A; Shyamsundar M BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33419742 [TBL] [Abstract][Full Text] [Related]
7. Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease. Chen R; Chen R; Chen X; Chen L Intern Med J; 2014 Aug; 44(8):791-800. PubMed ID: 24860934 [TBL] [Abstract][Full Text] [Related]
8. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol. Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111 [TBL] [Abstract][Full Text] [Related]
9. Minimal versus specialist equipment in the delivery of pulmonary rehabilitation: protocol for a non-inferiority randomised controlled trial. Nolan CM; Walsh JA; Patel S; Barker RE; Polgar O; Maddocks M; Gao W; Wilson R; Fiorentino F; Man W BMJ Open; 2021 Oct; 11(10):e047524. PubMed ID: 34663653 [TBL] [Abstract][Full Text] [Related]
10. Effect of a pulmonary rehabilitation programme of 8 weeks compared to 12 weeks duration on exercise capacity in people with chronic obstructive pulmonary disease (PuRe Duration): protocol for a randomised controlled trial. Bishop J; Spencer L; Alison J BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32933927 [TBL] [Abstract][Full Text] [Related]
11. Maintaining quality of life in patients with chronic obstructive pulmonary disease (COPD) by extending the maintenance phase of community-based pulmonary rehabilitation: protocol for a randomised controlled trial (ComEx3 Study). Lopez D; Cecins N; Cockram J; Collins A; Landers H; Sanfilippo F; Briffa T; Brims F; Geelhoed E; Murray K; Phillips K; Preen D; Jenkins S BMJ Open Respir Res; 2020 Mar; 7(1):. PubMed ID: 32209643 [TBL] [Abstract][Full Text] [Related]
12. High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial. Cortegiani A; Longhini F; Carlucci A; Scala R; Groff P; Bruni A; Garofalo E; Taliani MR; Maccari U; Vetrugno L; Lupia E; Misseri G; Comellini V; Giarratano A; Nava S; Navalesi P; Gregoretti C Trials; 2019 Jul; 20(1):450. PubMed ID: 31331372 [TBL] [Abstract][Full Text] [Related]
13. The effect of transcutaneous electrical nerve stimulation in patients with acute exacerbation of chronic obstructive pulmonary disease: randomised controlled trial. Öncü E; Zincir H J Clin Nurs; 2017 Jul; 26(13-14):1834-1844. PubMed ID: 27325551 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2). Kunadian V; Chan D; Ali H; Wilkinson N; Howe N; McColl E; Thornton J; von Wilamowitz-Moellendorff A; Holstein EM; Burns G; Fisher A; Stocken D; De Soyza A; BMJ Open; 2018 May; 8(5):e020713. PubMed ID: 29804061 [TBL] [Abstract][Full Text] [Related]
16. A randomised controlled trial to investigate the use of high-frequency airway oscillations as training to improve dyspnoea in COPD. Daynes E; Greening N; Sidiqqui S; Singh S ERJ Open Res; 2019 Jul; 5(3):. PubMed ID: 31367635 [TBL] [Abstract][Full Text] [Related]
17. Beta-alanine supplementation in patients with COPD receiving non-linear periodised exercise training or neuromuscular electrical stimulation: protocol of two randomised, double-blind, placebo-controlled trials. Meys R; Stoffels AAF; de Brandt J; van Hees HWH; Franssen FME; Sillen MJH; Wouters EFM; Burtin C; Klijn P; Bij de Vaate E; van den Borst B; Otker JM; Donkers J; Schleich FN; Hayot M; Pomiès P; Everaert I; Derave W; Spruit MA; BMJ Open; 2020 Sep; 10(9):e038836. PubMed ID: 32928863 [TBL] [Abstract][Full Text] [Related]
18. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol. Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110 [TBL] [Abstract][Full Text] [Related]
20. Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial. Li J; Luo J; Chen Y; Xie L; Fink JB BMJ Open; 2019 Jun; 9(6):e028584. PubMed ID: 31239304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]